Results: The age of the VIA positive patients 38.02 ± 10.41 (ranged 22 – 68) years with majority (88.4%) patients were in the age group of 22-50 years. Three-quarter of the women were multiparity. Colposcopic diagnosis was carcinoma in situ I (CINI) in 143 (57.2%) patients, CIN II in 37 (19.2%) patients CIN III in 26 (10.4%) patients, invasive cervical carcinoma in 17 (6.8%) patients and normal finding in 27 (10.8%) cases. Histpathologically 69 (27.6%) patients had carcinoma in situ (CIN) I, 49 (19.6%) patients had CIN II, 26 (10.4%) patients had CIN III, 45 (18.0%) patients had chronic cervicitis, 17 (6.8%) patients had endocervical polyp, 17 (6.8%) patients had invasive cervical carcinoma and biopsy was not done in 27 (10.8%) patients. All colposcopy positive CIN 2 (n=37), CIN 3 (n=26) and invasive carcinoma (n=17) were histopathologically proven CIN 2, CIN 3 and invasive carcinoma respectively. While 143 colposcopy positive CIN 1 cases were histopathologically CIN 1 (48.3%), CIN 2 (8.4%), chronic cervicitis (31.5%), and endocervical polyp (11.9%). Colposcopy correctly diagnosed CIN 2, CIN 3 and invasive carcinoma cervix but about half (52.3%) of the cases of CIN 1 compared to histopathology with overall accuracy of colposcopy was 71.7%.